We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HLLY:NYSEHolley Inc. Analysis

Data as of 2026-07-07 - not real-time

$2.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Holley Inc. (HLLY) is trading at $2.37, well below its 20‑day ($2.50), 50‑day ($2.72) and 200‑day ($3.39) simple moving averages, signaling a bearish price trend. RSI at 39 suggests the stock is approaching oversold territory, while the MACD line has just crossed above its signal line, producing a modest bullish histogram and a "bullish" MACD signal. Volume is on an increasing trend, providing the liquidity needed for a potential short‑term bounce toward the identified resistance of $2.66. Analyst consensus rates the stock as a Buy with a median target of $4.25 and a mean target of $4.67, implying roughly a 97% upside from current levels. Valuation multiples are attractive – PE 11.9x, forward PE 6.1x, price‑to‑sales 0.47x and price‑to‑book 0.62x – indicating the market may be undervaluing the business. However, the balance sheet is strained: debt‑to‑equity exceeds 128%, total debt ($584 M) dwarfs cash ($33 M), and free cash flow is negative ($‑5.9 M). Operating margins remain modest (operating margin 12.5%, profit margin 3.9%) and revenue is contracting at –3.7% YoY, underscoring execution risk. The company operates in the consumer‑cyclical auto‑parts sector, which is sensitive to economic cycles, and its beta of 1.4 points to higher volatility than the broader market. The 30‑day volatility of 56% and a historical max drawdown of –46% further highlight price risk. Despite these challenges, the combination of low valuation, strong analyst upside, and early technical reversal cues creates a compelling case for positioning now, especially for investors with a longer horizon.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price near support with increasing volume
  • RSI approaching oversold and MACD bullish crossover
  • Analyst upside potential exceeding 90%

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive valuation multiples relative to peers
  • Forward PE compression to 6.1x
  • Potential earnings recovery as Q1 results are released

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Significant upside to analyst price targets
  • Brand portfolio in a niche performance aftermarket segment
  • Opportunity to improve capital structure and cash generation over time

Key Metrics & Analysis

Financial Health

Revenue Growth-3.70%
Profit Margin3.89%
P/E Ratio11.8
ROE5.36%
ROA4.52%
Debt/Equity128.07
P/B Ratio0.6
Op. Cash Flow$51.2M
Free Cash Flow$-5882625

Technical Analysis

TrendBearish
RSI39.4
Support$2.33
Resistance$2.66
MA 20$2.50
MA 50$2.72
MA 200$3.39
MACDBullish
VolumeIncreasing
Fear & Greed Index93.14

Valuation

Target Price$4.67
Upside/Downside96.91%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.41
Volatility55.96%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.